These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

578 related items for PubMed ID: 21054236

  • 1. A comparison of tabun-inhibited rat brain acetylcholinesterase reactivation by three oximes (HI-6, obidoxime, and K048) in vivo detected by biochemical and histochemical techniques.
    Bajgar J, Hajek P, Zdarova JK, Kassa J, Paseka A, Slizova D, Krs O, Kuca K, Jun D, Fusek J, Capek L.
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):790-7. PubMed ID: 21054236
    [Abstract] [Full Text] [Related]

  • 2. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J, Karasova J, Musilek K, Kuca K.
    Toxicology; 2008 Jan 20; 243(3):311-6. PubMed ID: 18054821
    [Abstract] [Full Text] [Related]

  • 3. Combined approach to demonstrate acetylcholinesterase activity changes in the rat brain following tabun intoxication and its treatment.
    Bajgar J, Hajek P, Kassa J, Slizova D, Krs O, Karasova JZ, Fusek J, Capek L, Voicu VA.
    Toxicol Mech Methods; 2012 Jan 20; 22(1):60-6. PubMed ID: 21851296
    [Abstract] [Full Text] [Related]

  • 4. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
    Calić M, Vrdoljak AL, Radić B, Jelić D, Jun D, Kuca K, Kovarik Z.
    Toxicology; 2006 Feb 15; 219(1-3):85-96. PubMed ID: 16332406
    [Abstract] [Full Text] [Related]

  • 5. Effect of five acetylcholinesterase reactivators on tabun-intoxicated rats: induction of oxidative stress versus reactivation efficacy.
    Pohanka M, Karasova JZ, Musilek K, Kuca K, Kassa J.
    J Appl Toxicol; 2009 Aug 15; 29(6):483-8. PubMed ID: 19338015
    [Abstract] [Full Text] [Related]

  • 6. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J, Karasova JZ, Pavlikova R, Musilek K, Kuca K, Bajgar J, Jung YS.
    Toxicol Mech Methods; 2011 Mar 15; 21(3):241-5. PubMed ID: 21142778
    [Abstract] [Full Text] [Related]

  • 7. In vitro reactivation of tabun-inhibited acetylcholinesterase using new oximes--K027, K005, K033 and K048.
    Kuca K, Cabal J.
    Cent Eur J Public Health; 2004 Mar 15; 12 Suppl():S59-61. PubMed ID: 15141981
    [Abstract] [Full Text] [Related]

  • 8. Tabun-inhibited rat tissue and blood cholinesterases and their reactivation with the combination of trimedoxime and HI-6 in vivo.
    Bajgar J, Karasova JZ, Kassa J, Cabal J, Fusek J, Blaha V, Tesarova S.
    Chem Biol Interact; 2010 Sep 06; 187(1-3):287-90. PubMed ID: 20167212
    [Abstract] [Full Text] [Related]

  • 9. Bisquaternary oximes as reactivators of tabun-inhibited human brain cholinesterases: an in vitro study.
    Kuca K, Jun D, Cabal J, Musilova L.
    Basic Clin Pharmacol Toxicol; 2007 Jul 06; 101(1):25-8. PubMed ID: 17577312
    [Abstract] [Full Text] [Related]

  • 10. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.
    Kassa J, Karasova JZ, Caisberger F, Musilek K, Kuca K, Jung YS.
    J Enzyme Inhib Med Chem; 2010 Aug 06; 25(4):480-4. PubMed ID: 20233085
    [Abstract] [Full Text] [Related]

  • 11. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J, Karasova J, Musilek K, Kuca K, Bajgar J.
    Clin Toxicol (Phila); 2009 Jan 06; 47(1):72-6. PubMed ID: 18686075
    [Abstract] [Full Text] [Related]

  • 12. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
    Kassa J, Kunesova G.
    J Appl Toxicol; 2006 Jan 06; 26(4):309-16. PubMed ID: 16552727
    [Abstract] [Full Text] [Related]

  • 13. [A comparison of the efficacy of the reactivators of acetylcholinesterase inhibited with tabun].
    Cabal J, Kuca K, Jun D, Bajgar J, Hrabinová M.
    Ceska Slov Farm; 2005 Jul 06; 54(4):192-5. PubMed ID: 16124202
    [Abstract] [Full Text] [Related]

  • 14. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
    Kuca K, Cabal J, Kassa J.
    Pharmazie; 2004 Oct 06; 59(10):795-8. PubMed ID: 15544060
    [Abstract] [Full Text] [Related]

  • 15. Effective bisquaternary reactivators of tabun-inhibited AChE.
    Kuca K, Cabal J, Musilek K, Jun D, Bajgar J.
    J Appl Toxicol; 2005 Oct 06; 25(6):491-5. PubMed ID: 16092078
    [Abstract] [Full Text] [Related]

  • 16. A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice.
    Kassa J, Karasova J, Bajgar J, Kuca K, Musilek K, Kopelikova I.
    J Enzyme Inhib Med Chem; 2009 Aug 06; 24(4):1040-4. PubMed ID: 19552519
    [Abstract] [Full Text] [Related]

  • 17. A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods.
    Kassa J, Kuca K, Cabal J, Paar M.
    J Toxicol Environ Health A; 2006 Oct 06; 69(20):1875-82. PubMed ID: 16952906
    [Abstract] [Full Text] [Related]

  • 18. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testing.
    Bartosova L, Kuca K, Jun D, Kunesova G.
    Int J Toxicol; 2005 Oct 06; 24(6):399-402. PubMed ID: 16393932
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of the reactivating effect of BI-6, a new asymmetrical bispyridinium oxime, with oxime HI-6 and obidoxime on soman-inhibited acetylcholinesterase in the diaphragm and various parts of the brain in rats].
    Kassa J, Bajgar J.
    Cas Lek Cesk; 1999 Aug 30; 138(17):532-5. PubMed ID: 10566233
    [Abstract] [Full Text] [Related]

  • 20. A comparison of the potency of newly developed oximes (K074, K075) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
    Kassa J, Karasova J.
    Toxicology; 2007 Jan 05; 229(1-2):136-44. PubMed ID: 17141392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.